COOKIES: By using this website you agree that we can place Google Analytics Cookies on your device for performance monitoring. |
University of Cambridge > Talks.cam > Enterprise Tuesday 2012/2013 > Enterprise Tuesday 2012-2013: Funding your vision and plans (Angel Panel)
Enterprise Tuesday 2012-2013: Funding your vision and plans (Angel Panel)Add to your list(s) Download to your calendar using vCal
If you have a question about this talk, please contact Enterprise Tuesday. This session will include a number of elevator pitches by entrepreneurs seeking funding. There will be open Q&A and discussion with experienced business angels on the different ways of funding new start-ups and funding the early stages of survival. You will see how business angels react to an elevator pitch, hear their line of questioning and learn about crowd funding, angel syndicates, roll of grants, customers as a source of funding, partnerships and supplier credit. Business Angel Panel: • Sherry Coutu, Angel Investor & Entrepreneur • Jack Lang, Serial Entrepreneur and Business Angel • Robert Brady, Angel Investor and Non-Executive Director, Cambridge IP • Peter Cowley, Angel Investor and Director, Martlet • Monish Suri, Partner, Prime Ventures Interested? Please register at http://www.cfel.jbs.cam.ac.uk/programmes/enterprisetuesday/register.html Registration is from 18:00. The lecture starts at 18:30 followed by networking from 20:00. Plus there’s a chance to participate in a special discussion group with Sherry Coutu. Discussion Group – CUTEC Date: 26th February 2013, 20:00-21:00 – directly after the main Enterprise Tuesday lecture Venue: Board Room, 2nd floor, Department of Engineering Join CUTEC for a rare Q&A session with serial entrepreneur and angel investor Sherry Coutu. Voted by Techcrunch as the best CEO mentor/advisor in Europe in 2010 and as one of the top 25 ‘most influential people in the wired world’ by Wired magazine in 2011, Sherry plays an influential role in the Cambridge startup ecosystem. During this session, Sherry will canvas her progression from student to entrepreneur as well as her career beginning as a consultant designing databases for investment banks, to launching her first startup in 1995, Interactive Investor plc. Today Sherry Coutu supports multiple companies, though as a self-professed lover of Big-Data, many of the high growth startups she is involved in share this common theme. Attendance is limited, so please sign up now to avoid disappointment. Please register directly via http://qandawithsherrycoutu.eventbrite.com —- Enterprise Tuesday is a series of FREE evening lectures and networking sessions managed and delivered by the Centre for Entrepreneurial Learning (CfEL) at the University of Cambridge’s Judge Business School. This talk is part of the Enterprise Tuesday 2012/2013 series. This talk is included in these lists:
Note that ex-directory lists are not shown. |
Other listsThe obesity epidemic: Discussing the global health crisis Entrepreneurship for a Zero Carbon Society Quaternary Discussion Group (QDG) CUCS The Annual CCHSR Lecture 2016 International Political Theory Research Seminar SeriesOther talksThe Digital Doctor: Hope, Hype, and Harm at the Dawn of Medicine’s Computer Age Measuring interacting electrons in low dimensional systems: spin-charge separation and 'replicas & tbd Findings from Studies of Virtual Reality Sketching Making a Crowdsourced Task Attractive: Measuring Workers Pre-task Interactions Pruning and grafting syntactic trees for cross-lingual transfer tasks BP KEYNOTE LECTURE: Importance of C-O Bond Activation for CO2/COUtilization - An Approach to Energy Conversion and Storage Cambridge Rare Disease Summit 2017 Market Socialism and Community Rating in Health Insurance The Productivity Paradox: are we too busy to get anything done? Stereodivergent Catalysis, Strategies and Tactics Towards Secondary Metabolites as enabling tools for the Study of Natural Products Biology The MHC ligandome of two contagious cancers within the Tasmanian devil population, Devil Facial Tumour 1 and Devil Facial Tumour 2 |